drugset / Trial / NCT01221792
Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators hypothesize that carvedilol, at less then therapeutic doses for cardiac effect, will reduce symptoms of Post Traumatic Stress Disorder.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-06
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carvedilol | Other / unclassified | 6.25 mg | Oral |
| Comparator | Carvedilol | Other / unclassified | 15.625 mg | Oral |